A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients
Completed
Association for Innovation and Biomedical Research on Light and Image
Phase 4
2014-10-01
To provide treating physicians with experience with ILUVIEN as well as monitoring its safety
(and effectiveness) in a real-life chronic diabetic macular edema (DME) patients judged
insufficiently responsive to available therapies.
A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Co
Completed
Alimera Sciences
Phase 4
2014-01-01
A phase 4 trial evaluating the effect and safety of ILUVIEN in chronic DME patients
insufficiently responsive to available therapies.
Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study
Withdrawn
Johns Hopkins University
Phase 4
2017-03-01
Primary Objective:
• To collect post-approval safety data related to intraocular pressure (IOP) after one or
more injections of Iluvien as standard of care in subjects with diabetic macular edema (DME).
Secondary Objectives:
• To collect visual and anatomic outcome data after one or more injections of Iluvien as
standard of care in subjects with diabetic macular edema (DME).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
